Jinling Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinling Pharmaceutical Company Limited with three other
companies in this sector in China:
Shijiazhuang Yiling Pharmaceutical Co Ltd
sales of 3.18 billion Chinese Renmimbi [US$462.37 million]
of which 100%
Guizhou Yibai Pharmaceutical Co., Ltd.
(3.30 billion Chinese Renmimbi [US$479.53 million]
of which 14%
was Medicine), and
Sihuan Pharmaceutical Holdings Group Ltd
(3.17 billion Chinese Renmimbi [US$459.88 million]
of which 100%
was Pharmaceutical Prods).
Jinling Pharmaceutical Company Limited reported sales of 3.22 billion Chinese Renmimbi (US$467.39 million)
December of 2015.
increase of 16.2%
versus 2014, when the company's sales were 2.77 billion Chinese Renmimbi.
Sales at Jinling Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 49%).
Sales of Medical Service saw an increase
29.8% in 2015, from
539.30 million Chinese Renmimbi to 699.95 million Chinese Renmimbi.
Not all segments of Jinling Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Other Operations fell 12.3% to 193.25 million Chinese Renmimbi.